<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: pseudomonas</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Antibiotic may provide benefit for treatment of respiratory disorder</title>
   	 <description>Among patients with the lung disorder non-cystic fibrosis bronchiectasis, treatment with the antibiotic erythromycin resulted in improvement in symptoms but also increased the risk of antibiotic resistance, according to a study appearing in the March 27 issue of JAMA.</description>
	  <link>http://medicalxpress.com/news/2013-03-antibiotic-benefit-treatment-respiratory-disorder.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 26 Mar 2013 16:00:09 EST</pubDate>
	 <guid isPermaLink="false">news283523222</guid>
	 
</item>
<item>
     <title>Inhaler approved for cystic fibrosis patients</title>
   	 <description>(HealthDay)—The TOBI Podhaler (tobramycin inhalation powder) has been approved by the U.S. Food and Drug Administration to treat cystic fibrosis patients infected with Pseudomonas aeruginosa, a bacterium that can damage the lungs.</description>
	  <link>http://medicalxpress.com/news/2013-03-inhaler-cystic-fibrosis-patients.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 25 Mar 2013 17:50:01 EST</pubDate>
	 <guid isPermaLink="false">news283451913</guid>
	 
</item>
<item>
     <title>Scientists discover potential new target in fight against 'superbug'</title>
   	 <description>University of Cambridge researchers have discovered how an antibiotic-resistant superbug exploits oxygen-limited conditions in the lungs of patients with severe respiratory disease to thrive.</description>
	  <link>http://medicalxpress.com/news/2013-01-scientists-potential-superbug.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 29 Jan 2013 19:20:01 EST</pubDate>
	 <guid isPermaLink="false">news278677034</guid>
	 
</item>
<item>
     <title>Ultrasound gel and infections: Researchers propose guidelines to reduce risk</title>
   	 <description>In the December issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America, guidelines have been proposed by epidemiologists from Beaumont Health System to reduce the risk of infection from contaminated gels. The recommendations are based on the authors' own experiences with an outbreak traced to contaminated ultrasound transmission gel.</description>
	  <link>http://medicalxpress.com/news/2012-11-ultrasound-gel-infections-guidelines.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 12 Nov 2012 10:42:55 EST</pubDate>
	 <guid isPermaLink="false">news271939364</guid>
	 
</item>
<item>
     <title>New plasma jet gives 'cold' shoulder to 'superbugs'</title>
   	 <description>Scientists at Queen's University Belfast have developed a new technique which has the potential to kill off hospital superbugs like Pseudomonas aeruginosa, C. difficile and MRSA.</description>
	  <link>http://medicalxpress.com/news/2012-10-plasma-jet-cold-shoulder-superbugs.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 03 Oct 2012 09:40:55 EST</pubDate>
	 <guid isPermaLink="false">news268476045</guid>
	 
</item>
<item>
     <title>Healthy lungs' microbes focus of study on cystic fibrosis</title>
   	 <description>(Medical Xpress)—Healthy people's lungs are home to a diverse community of microbes that differs markedly from the bacteria found in the lungs of cystic fibrosis patients. That's the result of new research from Stanford University and Lucile Packard Children's Hospital, which has wide implications for treatment of cystic fibrosis and other lung diseases.</description>
	  <link>http://medicalxpress.com/news/2012-09-healthy-lungs-microbes-focus-cystic.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 27 Sep 2012 09:43:53 EST</pubDate>
	 <guid isPermaLink="false">news267957826</guid>
	 
</item>
<item>
     <title>P. aeruginosa bacteria associated with increased hospitalizations in COPD patients</title>
   	 <description>Patients with chronic obstructive pulmonary disease (COPD) who become infected with the bacterium Pseudomonas aerguinosa are more likely to have worse clinical outcomes and experience more hospitalizations during the course of their disease than COPD patients who are not infected, according to researchers from Buffalo, N.Y.</description>
	  <link>http://medicalxpress.com/news/2012-05-p-aeruginosa-bacteria-hospitalizations-copd.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 23 May 2012 14:00:15 EST</pubDate>
	 <guid isPermaLink="false">news256996604</guid>
	 
</item>
<item>
     <title>'Resuscitating' antibiotics to overcome drug resistance</title>
   	 <description>Combining common antibiotics with additional compounds could make previously resistant bacteria more susceptible to the same antibiotics. 'Resuscitation' of existing antibiotics has the potential to make infections caused by multidrug-resistant bacteria easier to control, reducing antibiotic usage and levels of antimicrobial resistance, say scientists presenting their work at the Society for General Microbiology's Spring Conference in Dublin this week.</description>
	  <link>http://medicalxpress.com/news/2012-03-resuscitating-antibiotics-drug-resistance.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 28 Mar 2012 03:25:40 EST</pubDate>
	 <guid isPermaLink="false">news252123929</guid>
	 
</item>
<item>
     <title>Clinical trial to test success of Cystic Fibrosis lung infection treatment</title>
   	 <description>Experts from Bristol and Nottingham are leading a major new national study to investigate whether intravenous antibiotics are effective in killing a common germ that causes dangerous complications in cystic fibrosis (CF) patients.</description>
	  <link>http://medicalxpress.com/news/2012-03-clinical-trial-success-cystic-fibrosis.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 27 Mar 2012 10:48:44 EST</pubDate>
	 <guid isPermaLink="false">news252064114</guid>
	 
</item>
<item>
     <title>Parallel evolution - cystic fibrosis</title>
   	 <description>(Medical Xpress) -- Researchers at the University of Liverpool are examining the evolution of Pseudomonas aeruginosa over time in the lungs of ten people with cystic fibrosis to understand why it persists in these patients and why its response to antibiotics is so varied.</description>
	  <link>http://medicalxpress.com/news/2012-03-parallel-evolution-cystic-fibrosis.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 06 Mar 2012 06:30:02 EST</pubDate>
	 <guid isPermaLink="false">news250237072</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/parallelevol.jpg" width="90" height="90" />
</item>
<item>
     <title>New automated system to kill bacteria in hospital water systems and taps</title>
   	 <description>A team of Trinity College Dublin researchers has developed a fully automated system that eradicates bacterial contamination in hospital water tanks, distribution systems and taps. This type of contamination was linked to the recent tragic deaths of three babies in a Belfast Maternity Hospital. The findings will be published in the April edition of Journal of Hospital Infection and have just been published online.</description>
	  <link>http://medicalxpress.com/news/2012-03-automated-bacteria-hospital.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 05 Mar 2012 09:40:01 EST</pubDate>
	 <guid isPermaLink="false">news250160943</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/newautomated.jpg" width="90" height="90" />
</item>
<item>
     <title>Early cystic fibrosis lung disease detected by bronchoalveolar lavage and lung clearance index</title>
   	 <description>The lung clearance index (LCI) is a sensitive non-invasive marker of early lung disease in young children with cystic fibrosis (CF), according to a new study from Australian researchers.</description>
	  <link>http://medicalxpress.com/news/2012-01-early-cystic-fibrosis-lung-disease.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 27 Jan 2012 04:40:02 EST</pubDate>
	 <guid isPermaLink="false">news246860690</guid>
	 
</item>
<item>
     <title>Targeting bacterial gas defenses allow for increased efficacy of numerous antibiotics</title>
   	 <description>Although scientists have known for centuries that many bacteria produce hydrogen sulfide (H2S) it was thought to be simply a toxic by-product of cellular activity. Now, researchers at NYU School of Medicine have discovered H2S in fact plays a major role in protecting bacteria from the effects of numerous different antibiotics.</description>
	  <link>http://medicalxpress.com/news/2011-11-bacterial-gas-defenses-efficacy-numerous.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 17 Nov 2011 15:28:37 EST</pubDate>
	 <guid isPermaLink="false">news240766107</guid>
	 
</item>
<item>
     <title>An antibiotic effect minus resistance</title>
   	 <description>After 70 years, antibiotics are still the primary treatment for halting the spread of bacterial infections. But the prevalence of antibiotic resistance is now outpacing the rate of new drug discovery and approval.</description>
	  <link>http://medicalxpress.com/news/2011-10-antibiotic-effect-resistance.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 28 Oct 2011 13:13:16 EST</pubDate>
	 <guid isPermaLink="false">news239026319</guid>
	 
</item>
<item>
     <title>Study proves new technology kills bacteria</title>
   	 <description>Results from a comprehensive multi-site clinical trial demonstrated that the use of antimicrobial copper surfaces in intensive care unit rooms reduced the amount of bacteria in the rooms by 97 percent and resulted in a 41 percent reduction in the hospital acquired infection rate. According to researchers, this study is one of the first to demonstrate the value of a passive infection control intervention, one that does not rely on staff or patients remembering to take action. The results will be presented on Friday, October 21 at the 2011 Annual Meeting of the Infectious Diseases Society of America in Boston.</description>
	  <link>http://medicalxpress.com/news/2011-10-technology-bacteria.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 20 Oct 2011 10:10:39 EST</pubDate>
	 <guid isPermaLink="false">news238324225</guid>
	 
</item>
<item>
     <title>Drug-resistant bacteria top agenda of medical convention</title>
   	 <description>The emergence of bacteria resistant to antibiotics and efforts by scientists trying to cope with the problem top the agenda at a medical convention under way here this weekend.</description>
	  <link>http://medicalxpress.com/news/2011-09-drug-resistant-bacteria-agenda-medical-convention.html</link>
	 <category>Health</category>
	 <pubDate>Sun, 18 Sep 2011 13:40:27 EST</pubDate>
	 <guid isPermaLink="false">news235572007</guid>
	 
</item>
<item>
     <title>Invasive diagnostic procedure for children with cystic fibrosis does not improve outcomes</title>
   	 <description>Compared to a standard diagnostic procedure, infants with cystic fibrosis who received treatment based on a diagnostic procedure involving obtaining and culturing fluid samples from the lungs did not have a lower prevalence of lung-damaging infection or structural lung injury at 5 years of age, according to a study in the July 13 issue of JAMA.</description>
	  <link>http://medicalxpress.com/news/2011-07-invasive-diagnostic-procedure-children-cystic.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 12 Jul 2011 16:49:24 EST</pubDate>
	 <guid isPermaLink="false">news229708092</guid>
	 
</item>
<item>
     <title>Bacterial infection alone not an indicator of poor lung function in adolescents with CF</title>
   	 <description>Children with cystic fibrosis (CF) who have poor lung function early in life are more likely also to have poor lung function in adolescence, regardless of whether they are exposed to a common infection caused by the bacteria Pseudomonas aeruginosa in early childhood. Earlier studies had indicated infection with the bacteria early in life was strongly associated with poor lung function later on.</description>
	  <link>http://medicalxpress.com/news/2011-05-bacterial-infection-indicator-poor-lung.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 16 May 2011 10:38:55 EST</pubDate>
	 <guid isPermaLink="false">news224761091</guid>
	 
</item>


</channel>
</rss>
